바이오시밀러 시장은 2024-2029년 1,176억 7,810만 달러 증가하고, 예측 기간 중 34.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 세계의 바이오시밀러(Biosimilars) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 바이오시밀러 시장은 바이오시밀러의 바이오의약품 대비 가격 우위, 주요 바이오의약품의 특허 만료, 바이오시밀러 의약품의 사용을 늘리기 위한 정부의 이니셔티브에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2025년) |
25.6% |
| CAGR |
34.2% |
| 증가액 |
1,176억 7,810만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이번 조사에서는 향후 몇 년간 바이오시밀러 시장의 성장을 가속하는 주요 이유 중 하나로 바이오시밀러로의 전환 의향을 꼽았습니다. 또한, 각국의 바이오시밀러에 대한 치료 호환성 규제 및 특허 무용론은 시장의 큰 수요로 이어질 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2024년)
- 시장 전망(2024-2029년)
제5장 시장 규모 실적
- 세계의 바이오시밀러 시장(2019-2023년)
- 제품 유형별 부문 분석(2019-2023년)
- 용도별 부문 분석(2019-2023년)
- 제조업 유형별 부문 분석(2019-2023년)
- 지역별 부문 분석(2019-2023년)
- 국가별 부문 분석(2019-2023년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 제품 유형별
- 시장 부문
- 비교 : 제품 유형별
- 단일클론항체 : 시장 규모와 예측(2024-2029년)
- 인슐린 : 시장 규모와 예측(2024-2029년)
- 인간성장호르몬 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 제품 유형별
제9장 시장 세분화 : 용도별
- 시장 부문
- 비교 : 용도별
- 종양학 및 혈액학 : 시장 규모와 예측(2024-2029년)
- 내분비학 : 시장 규모와 예측(2024-2029년)
- 면역학 : 시장 규모와 예측(2024-2029년)
- 신장학 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 용도별
제10장 시장 세분화 : 제조 유형별
- 시장 부문
- 비교 : 제조 유형별
- 자사 제조 : 시장 규모와 예측(2024-2029년)
- 계약 제조 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 제조 유형별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 유럽 : 시장 규모와 예측(2024-2029년)
- 북미 : 시장 규모와 예측(2024-2029년)
- 아시아 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 독일 : 시장 규모와 예측(2024-2029년)
- 미국 : 시장 규모와 예측(2024-2029년)
- 영국 : 시장 규모와 예측(2024-2029년)
- 중국 : 시장 규모와 예측(2024-2029년)
- 프랑스 : 시장 규모와 예측(2024-2029년)
- 한국 : 시장 규모와 예측(2024-2029년)
- 캐나다 : 시장 규모와 예측(2024-2029년)
- 일본 : 시장 규모와 예측(2024-2029년)
- 브라질 : 시장 규모와 예측(2024-2029년)
- 아랍에미리트(UAE) : 시장 규모와 예측(2024-2029년)
- 지역 상황에 의한 시장 기회
제13장 성장 촉진요인, 과제, 기회, 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제14장 경쟁 구도
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- AbbVie Inc.
- Amgen Inc.
- Biocon Ltd.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Celltrion Healthcare Co. Ltd.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Fresenius SE and Co. KGaA
- Gedeon Richter Plc
- Halozyme Therapeutics Inc.
- Intas Pharmaceuticals Ltd.
- Mabion S.A.
- Novartis AG
- Viatris Inc.
제16장 부록
LSH
The biosimilars market is forecasted to grow by USD 117678.1 million during 2024-2029, accelerating at a CAGR of 34.2% during the forecast period. The report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by price advantage of biosimilars over biologics, patent expiry of major biologics, and government initiatives to increase use of biosimilar medicines.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 25.6% |
| CAGR | 34.2% |
| Incremental Value | $117678.1 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's biosimilars market is segmented as below:
By Product Type
- Monoclonal antibodies
- Insulin
- Human growth hormone
- Others
By Application
- Oncology and hematology
- Endocrinology
- Immunology
- Nephrology
By Manufacturing Type
- In-house manufacturing
- Contract manufacturing
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
This study identifies the willingness to switch to biosimilars as one of the prime reasons driving the biosimilars market growth during the next few years. Also, therapeutic interchangeability regulations for biosimilars across countries and patent dance will lead to sizable demand in the market.
The report on the biosimilars market covers the following areas:
- Biosimilars Market sizing
- Biosimilars Market forecast
- Biosimilars Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., DR Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter PLC, Halozyme Therapeutics Inc., Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Biosimilars Market 2019 - 2023
- Historic Market Size - Data Table on Global Biosimilars Market 2019 - 2023 ($ million)
- 5.2 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.4 Manufacturing Type segment analysis 2019 - 2023
- Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 AI Impact on Global Biosimilars Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type
- 8.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
- 8.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- 8.3 Monoclonal antibodies - Market size and forecast 2024-2029
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- 8.4 Insulin - Market size and forecast 2024-2029
- Chart on Insulin - Market size and forecast 2024-2029 ($ million)
- Data Table on Insulin - Market size and forecast 2024-2029 ($ million)
- Chart on Insulin - Year-over-year growth 2024-2029 (%)
- Data Table on Insulin - Year-over-year growth 2024-2029 (%)
- 8.5 Human growth hormone - Market size and forecast 2024-2029
- Chart on Human growth hormone - Market size and forecast 2024-2029 ($ million)
- Data Table on Human growth hormone - Market size and forecast 2024-2029 ($ million)
- Chart on Human growth hormone - Year-over-year growth 2024-2029 (%)
- Data Table on Human growth hormone - Year-over-year growth 2024-2029 (%)
- 8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 9.3 Oncology and hematology - Market size and forecast 2024-2029
- Chart on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology and hematology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology and hematology - Year-over-year growth 2024-2029 (%)
- 9.4 Endocrinology - Market size and forecast 2024-2029
- Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
- Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
- Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
- Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
- 9.5 Immunology - Market size and forecast 2024-2029
- Chart on Immunology - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
- Chart on Immunology - Year-over-year growth 2024-2029 (%)
- Data Table on Immunology - Year-over-year growth 2024-2029 (%)
- 9.6 Nephrology - Market size and forecast 2024-2029
- Chart on Nephrology - Market size and forecast 2024-2029 ($ million)
- Data Table on Nephrology - Market size and forecast 2024-2029 ($ million)
- Chart on Nephrology - Year-over-year growth 2024-2029 (%)
- Data Table on Nephrology - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Manufacturing Type
- 10.1 Market segments
- Chart on Manufacturing Type - Market share 2024-2029 (%)
- Data Table on Manufacturing Type - Market share 2024-2029 (%)
- 10.2 Comparison by Manufacturing Type
- Chart on Comparison by Manufacturing Type
- Data Table on Comparison by Manufacturing Type
- 10.3 In-house manufacturing - Market size and forecast 2024-2029
- Chart on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on In-house manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on In-house manufacturing - Year-over-year growth 2024-2029 (%)
- 10.4 Contract manufacturing - Market size and forecast 2024-2029
- Chart on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on Contract manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on Contract manufacturing - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ million)
- Data Table on Market opportunity by Manufacturing Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.12 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.16 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- 15.6 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
- 15.7 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- 15.8 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 15.9 Celltrion Healthcare Co. Ltd.
- Celltrion Healthcare Co. Ltd. - Overview
- Celltrion Healthcare Co. Ltd. - Business segments
- Celltrion Healthcare Co. Ltd. - Key offerings
- Celltrion Healthcare Co. Ltd. - Segment focus
- SWOT
- 15.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.12 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus
- SWOT
- 15.13 Gedeon Richter Plc
- Gedeon Richter Plc - Overview
- Gedeon Richter Plc - Business segments
- Gedeon Richter Plc - Key offerings
- Gedeon Richter Plc - Segment focus
- SWOT
- 15.14 Halozyme Therapeutics Inc.
- Halozyme Therapeutics Inc. - Overview
- Halozyme Therapeutics Inc. - Product / Service
- Halozyme Therapeutics Inc. - Key offerings
- SWOT
- 15.15 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
- 15.16 Mabion S.A.
- Mabion S.A. - Overview
- Mabion S.A. - Product / Service
- Mabion S.A. - Key offerings
- SWOT
- 15.17 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
